NASDAQ:KROS | Cash Flow Statement | Keros Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2019-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$28.71M
2026-03-31-$23.71M-$3.53M$73,000.00-$73,000.00-$2.32M
2025-12-31-$23.46M-$27.29M$134,000.00-$134,000.00-$378.63M
2025-09-30-$7.28M
2025-06-30-$30.7M
2025-03-31$148.45M$161.17M$565,000.00-$565,000.00$4,000.00
2024-12-31-$46.03M-$46.01M$289,000.00-$289,000.00$75.54M
2024-09-30-$52.96M
2024-06-30-$45.26M
2024-03-31-$43.11M-$44.56M$946,000.00-$946,000.00$156.8M
2023-12-31-$40.24M-$25.46M$541,000.00-$541,000.00$69.25M
2023-09-30-$39.44M
2023-06-30-$37.51M
2023-03-31-$35.8M-$34.24M$1.06M-$1.06M$107.68M
2022-12-31-$29.72M-$21.44M$351,000.00-$351,000.00$61.42M
2022-09-30-$23.51M
2022-06-30-$27.27M
2022-03-31-$24.19M-$1.43M$147,000.00-$147,000.00$118,000.00
2021-12-31-$6.94M-$19.57M$159,000.00-$159,000.00$28.42M
2021-09-30-$20.3M
2021-06-30-$15.62M
2021-03-31-$15.89M-$10.51M$210,000.00-$210,000.00$42,000.00
2020-12-31-$10.68M-$7.99M$60,000.00-$60,000.00$140.12M
2020-09-30-$12.04M
2020-06-30-$10.76M
2020-03-31-$11.89M-$8.12M$176,000.00-$176,000.00$55.79M
2019-12-31-$2.75M-$5.5M$18,000.00-$18,000.00$4,000.00
2019-09-30-$3.55M
2019-06-30-$2.85M
2019-03-31-$3.18M-$2.51M$0.00$0.00$0.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31$87.01M$107.51M$1.55M-$1.55M$375M-$378.47M
2024-12-31-$187.35M-$160.87M$1.93M-$1.93M$0.00$391.82M
2023-12-31-$152.99M-$124.51M$2.46M-$2.46M$178.96M
2022-12-31-$104.68M-$70.06M$1.24M-$1.24M$120.31M
2021-12-31-$58.74M-$62.15M$1.02M-$1.02M$28.55M
2020-12-31-$45.36M-$36.89M$294,000.00-$294,000.00$296.04M
2019-12-31-$12.34M-$16M$271,000.00-$271,000.00$14,000.00